(Press-News.org) The University of Texas at Arlington is expanding its research and innovation capabilities by building a $2.3 million, state-of-the-art outdoor netted drone facility. The Maverick Autonomous Vehicle Research Center (MAVRC) will be located at the UT Arlington Research Institute (UTARI) in Fort Worth, with a planned completion date of January 2025.
“MAVRC will significantly and positively impact UTA’s presence in the region by supporting the university-industry-government-community ecosystem focused on autonomous and intelligent urban mobility systems that can be used in everything from self-driving cars and home package delivery to military and emergency response tools,” said Kate C. Miller, vice president for research and innovation at UTA. “A facility like this is necessary as more and more organizations move toward using autonomous vehicles. Just this week, UTA and the city of Arlington are demonstrating air robot deliveries in east Arlington as part of an ongoing project with the U.S. Department of Energy.”
The planned facility will be a netted structure equipped with lighting, an advanced suite of cameras and other sensors, and an adjacent control/education building. MAVRC aims to enhance research opportunities for faculty and students across UTA, area companies, local municipalities, and the community and allow for teaching, training, and outreach activities. These facilities are important for research as they allow for testing in all weather conditions, which is necessary for Federal Aviation Administration compliance.
“UTARI already has a smaller indoor drone facility. This new facility will greatly improve our research capabilities,” said Eileen D. Clements, interim executive director of UTARI. “This is a perfect addition to UTARI, where we specialize in applying cutting-edge technologies to real-world engineering problems. We are excited for all the new opportunities this facility will enable for UTA faculty, researchers, and students, as well as our business partners in the North Texas community.”
MAVRC will build on the existing research capabilities of UTARI’s Autonomous Systems Laboratory (ASL), led by Frank Lewis, professor of electrical engineering, and Nicholas Gans, head of UTARI’s Automation and Intelligent Systems Division. ASL currently focuses on research in controls design for autonomous vehicles. The lab also works on cooperative control of networked teams, sensor networks, and real-time control implementation.
This new resource also will complement and expand existing autonomous vehicle research at UT Arlington. Yan Wan, professor of electrical engineering who spearheaded the MAVRC project, is currently working on an airborne computing platform to enable unmanned aerial vehicles to help first responders better coordinate their efforts during emergencies. She also works on urban aerial mobility research, which has commercial applications, with many retailers studying how to use drones to deliver goods and services.
“Unmanned vehicles have phenomenal capabilities, but we must also consider how these ‘robots in the air’ talk to each other to avoid collisions and perform collaborative tasks,” said Dr. Wan. “The new facility at UTARI will allow myself, other researchers, and UTA students, plus local companies and stakeholders, to safely test and experiment with unmanned vehicles as our society speeds up its use of these technical marvels.”
“This outdoor test facility for air and ground autonomous vehicles is crucial for advancing and preparing the next generation of unmanned systems,” added Hongtei Eric Tseng, a renowned expert in vehicle autonomy and member of the National Academy of Engineering who joined UT Arlington in May as part of the Recruiting Innovative Scholars for Excellence (RISE 100) initiative. “I’m excited to have another UTA facility where we can work with students, faculty, and industry to develop cutting-edge technologies and applications. It will enhance our ability to innovate and lead cross-institutional research."
The netted facility is yet another investment in the North Texas region by UTA. In August, the University announced plans to build UTA West, a new campus in western Fort Worth dedicated to fostering economic development and meeting the educational needs of one of the fastest-growing areas in the country. UTA West is projected to enroll students as early as fall 2028 and will be developed as part of a multiyear plan to serve more than 10,000 students.
END
UTA to build netted drone facility in Fort Worth
Center will enhance research and development of autonomous vehicles
2024-09-10
ELSE PRESS RELEASES FROM THIS DATE:
Streamlining energy regulations on Native American reservations could help alleviate poverty
2024-09-10
MADISON–Land was once set aside as Native American reservations because it was undesirable and low in resources, but now interested Native Americans may have economic leverage in the growing industry of clean energy. A team of researchers led by UW–Madison professors Dominic Parker and Sarah Johnston quantified the economic potential of wind and solar energy projects on these lands and discussed the regulatory barriers for tribes wishing to tap into it.
“This is the first comprehensive ...
UT microbiologist Wilhelm honored as Fellow of the Royal Society of Canada
2024-09-10
Steven Wilhelm joins a distinguished roster this year with his election as a fellow of the Royal Society of Canada (RSC) Academy of Science. This recognition is the RSC’s highest honor in areas of arts, social sciences, humanities, and science.
“The RSC inducts fellows to help them build a better future in Canada and the world. As a native Canadian, this honor is the pinnacle of what I could have hoped for in my career,” said Wilhelm, the Kenneth and Blaire Mossman Professor in UT’s Department of Microbiology. “It also provides an opportunity for me to work with my collaborators ...
NCCN Policy Summit explores how to build an inclusive cancer center workplace culture that better serves everybody
2024-09-10
WASHINGTON, D.C. [September 10, 2024] — The National Comprehensive Cancer Network® (NCCN®) held an oncology policy summit today in Washington, D.C., focused on Advancing Diversity, Equity, and Inclusion in the Cancer Workforce. The event featured a keynote address from Tiffany Wallace, PhD, Branch Director, Disparities Research Branch, National Cancer Institute (NCI) Center for Cancer Health Equity. Panel discussions focused on how to establish and prioritize a culture of diversity, equity, inclusion, and belonging and maintain the commitment through a changing policy landscape. A series of ...
Games, puzzles and reading can slow cognitive decline in the elderly — even in those with mild cognitive impairment
2024-09-10
By Ann Kellett, Texas A&M University School of Public Health
The aging process can lead to diminished cognitive functioning for older adults. In addition, about 10 percent of people previously diagnosed with mild cognitive impairment develop Alzheimer’s disease or other forms of dementia every year.
Although a few studies have found that activities such as putting together jigsaw puzzles can protect against cognitive aging, the benefits of these activities in preventing or postponing cognitive ...
An antidiabetic helps the immune system recognize reservoirs of HIV
2024-09-10
Researchers at Université de Montréal’s affiliated hospital research centre, the CRCHUM, say the discovery could help lessen and even eliminate viral loads in people undergoing antiretroviral therapy.
Metformin, a drug used to treat type 2 diabetes, could help deplete the viral reservoir and eliminate it entirely in people living with HIV who receive antiretroviral therapy, Canadian researchers say in a new study.
In 2021, a team led by immunologist Petronela Ancuta of Université de Montréal’s affiliated hospital research centre, ...
Department of Energy grant advances clean energy studies
2024-09-10
Dr. Berna Hascakir, professor in the Harold Vance Department of Petroleum Engineering at Texas A&M University, was selected as part of a $17 million grant from the U.S. Department of Energy’s (DOE) Office of Fossil Energy and Carbon Management. The investment will support university-led projects that advance decarbonization and net-zero greenhouse gas emissions.
In partnership with Texas A&M, Texas Tech University, Howard University, and the University at Buffalo, this initiative unites three minority-serving ...
Finding the right path(way) to reduce fat accumulation in the liver
2024-09-10
Using a novel stem cell platform, a team of Medical University of South Carolina researchers has identified a pathway that could be targeted by drugs to reduce fat accumulation in patients with a common form of fatty liver disease known as metabolic dysfunction-associated steatotic liver disease, or MASLD. The MUSC team was led by Stephen Duncan, Ph.D., SmartState Endowed Chair in Regenerative Medicine at MUSC, and Caren Doueiry, an M.D., Ph.D. candidate in Duncan’s laboratory. The team reports its findings in the International Journal of Molecular Sciences.
Almost a quarter of Americans have MASLD, formerly known as non-alcoholic fatty liver disease. It ...
MicroDicer and MicroGrater make quick work of tumor dissection
2024-09-10
As fascinating as it is to work in a modern biology lab, in many cases a lot of repetitive, detailed work is necessary before the research can start. For example, cancer researchers are now capable of using hundreds or even thousands of small, lab-grown tumor samples – known as organoids – to test multiple cancer therapies, including immunotherapies, at once.
To produce organoids, researchers often need to mince a fresh tumor into small pieces by hand, using scissors to snip, snip, snip the specimen down to submillimeter size. This dissection work is tedious and yet often done by skilled – and usually overqualified ...
Phase II study of taletrectinib shows clinically meaningful overall response and favorable safety in patients with ROS1+ non-small cell lung cancer
2024-09-10
(San Diego, Calif.--September 10, 2024, 10:35 a.m. PCT) – The ROS1 tyrosine kinase inhibitor (TKI) taletrectinib demonstrated high overall and intracranial responses, and a favorable safety profile with low incidence of neurologic adverse events in TKI-naive and TKI-pretreated patients with ROS1+ non-small cell lung cancer (NSCLC).
These results were presented today at the International Association for the Study of Lung Cancer 2024 World Conference on Lung Cancer by Dr. Geoffrey Liu, from Princess Margaret Cancer Centre, ...
LUMINOSITY trial demonstrates telisotuzumab vedotin shows durable response in Asian patients with c-Met protein-overexpressing EGFR WT nonsquamous NSCLC
2024-09-10
LUMINOSITY Trial Demonstrates Telisotuzumab Vedotin Shows Durable Response in Asian Patients with c-Met Protein-Overexpressing EGFR WT Nonsquamous NSCLC
(San Diego, Calif.--September 10, 2024 10:35 a.m.) -- The c-Met-directed antibody-drug conjugate telisotuzumab vedotin demonstrated durable responses and an acceptable safety profile in patients of Asian race with c-Met protein-overexpressing, epidermal growth factor receptor (EGFR) wildtype (WT), locally advanced/metastatic nonsquamous non-small cell ...
LAST 30 PRESS RELEASES:
Metformin changes blood metal levels in humans
Long-term anticoagulation discontinuation after catheter ablation for atrial fibrillation
Fractional flow reserve–guided complete vs culprit-only revascularization in non–ST-elevation myocardial infarction and multivessel disease
Participation of women in cardiovascular trials from 2017 to 2023
Semaglutide and tirzepatide in patients with heart failure with preserved ejection fraction
Changes in biology of internal fat may be the leading cause of heart failure
Transcatheter or surgical treatment of patients with aortic stenosis at low to intermediate risk
Promising new drug for people with stubborn high blood pressure
One shot of RSV vaccine effective against hospitalization in older adults for two seasons
Bivalent RSV prefusion F protein–based vaccine for preventing cardiovascular hospitalizations in older adults
Clonal hematopoiesis and risk of new-onset myocarditis and pericarditis
Risk of myocarditis or pericarditis with high-dose vs standard-dose influenza vaccine
High-dose vs standard-dose influenza vaccine and cardiovascular outcomes in older adults
Prevalence, determinants, and time trends of cardiovascular health in the WHO African region
New study finds that, after a heart attack, women have worse prognosis when treated with beta-blockers
CNIC-led REBOOT clinical trial challenges 40-year-old standard of care for heart attack patients
Systolic blood pressure and microaxial flow pump–associated survival in infarct-related cardiogenic shock
Beta blockers, the standard treatment after a heart attack, may offer no benefit for heart attack patients and women can have worse outcomes
High Mountain Asia’s shrinking glaciers linked to monsoon changes
All DRII-ed up: How do plants recover after drought?
Research on stigma says to just ‘shake it off’
Scientists track lightning “pollution” in real time using NASA satellite
Millions of women rely on contraceptives, but new Rice study shows they may do more than just prevent pregnancy
Hot days make for icy weather, Philippine study finds
Roxana Mehran, MD, receives the most prestigious award given by the European Society of Cardiology
World's first clinical trial showing lubiprostone aids kidney function
Capturing language change through the genes
Public trust in elections increases with clear facts
Thawing permafrost raised carbon dioxide levels after the last ice age
New DNA test reveals plants’ hidden climate role
[Press-News.org] UTA to build netted drone facility in Fort WorthCenter will enhance research and development of autonomous vehicles